Spelling suggestions: "subject:"mycobacterium tuberculosis,"" "subject:"nycobacterium tuberculosis,""
491 |
Les L,D‐transpeptidases, cibles des carbapénèmes chez Mycobacterium tuberculosis / The L,D-transpeptidases, the targets of carbapenems in Mycobacterium tuberculosisCordillot, Mathilde 20 November 2013 (has links)
Mycobacterium tuberculosis est responsable de 8,7 millions de nouveaux cas de tuberculose et de 1,4 millions de décès en 2011. L’émergence de souches résistantes aux deux antituberculeux majeurs, isoniazide et rifampicine, (MDR) et aux antibiotiques de seconde ligne (XDR), ainsi que la difficulté d’éradiquer les formes « dormantes » du bacille nécessitent la recherche de nouveaux antibiotiques. Les β-lactamines n’ont jamais été utilisées en thérapeutique car M. tuberculosis produit une β-lactamase à large spectre, BlaC. Cependant, l’association d’une β-lactamine appartenant à la classe des carbapénèmes, le méropénème, et d’un inhibiteur de β-lactamase, l’acide clavulanique, est active sur M. tuberculosis incluant des souches XDR. Notre objectif a été de caractériser les cibles des carbapénèmes qui sont atypiques chez M. tuberculosis, parce que le peptidoglycane de cette bactérie contient majoritairement (80%) des ponts interpeptidiques formés par une classe particulière de transpeptidases, les L,D-transpeptidases. Nous avons comparé les cinq L,D-transpeptidases de M. tuberculosis au niveau de leur activité in vitro dans la formation des ponts interpeptidiques du peptidoglycane et dans la réaction d’inactivation par les carbapénèmes. Nous avons ainsi pu montrer que les cinq L,D-transpeptidases sont fonctionnelles in vitro. LdtMt1, LdtMt2, LdtMt4 et LdtMt5 sont capables de former des ponts interpeptidiques du peptidoglycane reliant l’acide aminé en position 3 d’un substrat tétrapeptidique donneur à l’acide aminé en position 3 d’un substrat tétrapeptidique accepteur. Ces mêmes enzymes peuvent également utiliser la D-méthionine comme accepteur dans une réaction d’échange de la D-Ala4 du substrat tétrapeptidique. LdtMt1, LdtMt2, LdtMt3 et LdtMt4 forment un complexe covalent avec les carbapénèmes. La réaction d’inactivation des L,D-transpeptidases par les carbapénèmes se déroulent en deux étapes. Dans un premier temps, un intermédiaire covalent réversible est formé (constante catalytique k1) puis la deuxième étape aboutit à la formation de l’acylenzyme (constante catalytique k2). La détermination des constantes catalytiques d’inactivation k1 et k2 a révélé d’importantes différences entre les carbapénèmes. Excepté pour LdtMt1, l’imipénème inactive plus rapidement les L,D-transpeptidases que les autres carbapénèmes suggérant que des modifications de la chaine latérale pourraient être envisagées pour optimiser l’activité « anti-mycobactérienne » de cette classe de β-lactamines. Nous avons en parallèle initié l’étude de la régulation des L,D-transpeptidases dans différentes conditions de culture ce qui permettra à terme d’identifier les L,D-transpeptidases essentielles pour la croissance et la persistance de M. tuberculosis. Ce travail pourrait déboucher sur l’identification de cibles essentielles permettant l’éradication des formes dormantes de M. tuberculosis qui sont très difficile à traiter. / Mycobacterium tuberculosis is responsible for 8.7 million of new cases of tuberculosis (TB) and 1.4 million of deaths in 2011. The emergence of strains resistant to the two first-line anti-TB drugs, isoniazid and rifampicin, (MDR), to second line-drugs (XDR) and the difficult to kill dormant forms of the bacilli require the discovery of new anti-TB antibiotics. β-lactams are usually not considered for tuberculosis treatment since M. tuberculosis produces a broad-spectrum β-lactamase, BlaC. However, the combination of β-lactam belonging to the carbapenem class, meropenem, with β-lactamase inhibitor, clavulanate, is notably active on XDR strains. Our aim was to characterize the carbapenem targets, atypical in M. tuberculosis, since peptidoglycan of this bacteria contains a majority (80%) of cross-links formed by a special transpeptidase family, the L,D-transpeptidases. We have compared the five L,D-transpeptidases of M. tuberculosis for their in vitro activities with respect to peptidoglycan dimers formation and for inactivation reaction by carbapenems. Thus, we have showed that the five L,D-transpeptidases were functional in vitro. LdtMt1, LdtMt2, LdtMt4 et LdtMt5 were able to form peptidoglycan cross-links binding the third amino acid of a donor tetrapeptide substrate with the third amino acid of an acceptor tetrapeptide substrate. These enzymes were also able to use D-methionine as an acceptor in exchange reaction of D-Ala4 of the donor tetrapeptide substrate. LdtMt1, LdtMt2, LdtMt3 et LdtMt4 formed a covalent adduct with carbapenems. The inactivation reaction of L,D-transpeptidases by carbapenems proceed through two steps. In first, a reversible covalent adduct is formed (catalytic constant k1), followed by a second step leading to acylenzyme formation (catalytic constant k2). The determination of kinetic constants of inactivation k1 et k2 revealed important differences between carbapenems. Except for LdtMt1, Imipenem inactivates L,D-transpeptidases more rapidly than other carbapenems indicating that modification of the carbapenem side chain could be used to optimize their anti-mycobacterial activity. In parallel, we have started the study of the L,D-transpeptidases regulation in various culture conditions will allow identifying the L,D-transpeptidases essential for growth and persistence of M. tuberculosis. This work might lead to identification of essential targets allowing eradication of M. tuberculosis dormant forms, which are difficult to treat with conventional anti-TB drugs.
|
492 |
Analyse de la fonction de deux nouvelles lectines de type C, DCIR et CL-LK, dans l'immunité anti-tuberculeuse / Deciphering the function of two novel C type lectins, DCIR and CL-LK, in anti-tuberculosis immunityTroegeler, Anthony 29 September 2016 (has links)
La tuberculose (TB) est une maladie très répandue qui provoque la mort de plus d'un million de personnes dans le monde chaque année. Cela représente un véritable problème de santé publique qui nécessite le développement de nouveaux médicaments et traitements afin de mieux lutter contre cette maladie destructrice. Dans ce contexte, il est important de comprendre la relation entre l'agent étiologique, Mycobacterium tuberculosis (Mtb) et le système immunitaire. Les mycobactéries sont recouvertes de structure glycolipidiques qui pourraient être reconnus par des récepteur spécifiques appelés lectine de type C. Ici, nous avons étudié le rôle de deux lectines récemment identifiées qui n'ont pas été étudié dans un contexte de TB, CL-LK et DCIR. Au cours des dernières années, de nouvelles lectines solubles ont été identifiées et parmi elles ; CL-K1 a été définie par un criblage de divers ligands glycosylés, comme étant un potentiel récepteur de motifs présents sur la paroi de Mtb. Dans le sang, CL-K1 est associé avec une autre lectine soluble du nom de CL-L1, formant un complexe du nom de CL-LK. Par des expériences in vitro, notamment via des approches biochimique et d'analyses cytométriques, nous avons pu confirmer que CL-LK peut se lier à Mtb et encore plus particulièrement à la coiffe mannose présent sur le lipoarabinomannane, un constituant majeur de la mycomembrane. Les souris déficientes en CL-K1, une sous unités de CL-LK, ne présentent pas d'altération particulière de susceptibilité à Mtb. Cependant, nous avons pu mettre en évidence que la quantité de CL-LK dans le sérum de patient atteint d'une TB active est réduite comparé aux patients contrôles, et que cela corrèle de manière inverse à la réponse immune induite par le pathogène. Ces résultats indiquent que CL-LK pourrait présenter un intérêt comme élément de futur diagnostics ou suivi de traitement. Dans une seconde partie de la thèse, nous nous sommes concentré sur la lectine DCIR dans la réponse immune envers l'agent étiologique de la TB. DCIR est exprimé dans les lésions pulmonaires de macaques infectés par Mtb à la fois durant les infections asymptomatiques et dans les infections conduisant à une TB active. In vitro, une analyse globale de l'expression génique couplée à des validations par RT-qPCR ont pu révéler que suite à une infection par Mtb, l'expression d'un grand nombre de gènes répondant à l'interféron (IFN) de type I est inhibée dans les cellules dendritiques issues de moelle osseuses de souris déficientes en DCIR comparées à celles issues de souris sauvages. Cette inhibition corrèle avec une phosphorylation excessive de SHP2 dans les cellules dépourvues de DCIR, suivies d'une déphosphorylation de STAT1, laquelle est impliquée dans la régulation de la réponse à l'IFN de type I. L' IFN de type I est connu comme pouvant inhiber la production d' IL-12 dans les cellules dendritiques, et en effet, nous avons pu démontrer que l'inhibition de la signalisation relative à l'IFN de type I dans les cellules dendritiques déficientes en DCIR est associée avec une augmentation de la production d'IL12p70 ainsi qu'à une plus grande capacité de ces cellules à stimuler la prolifération de lymphocytes Th1 producteur d'IFN?. Les souris déficientes en DCIR contrôlent mieux l'infection que les souris sauvages, ce qui corrèle également avec une plus grande production d'IL12p70, une plus forte réponse des lymphocytes Th1, ainsi qu'à une augmentation de l'inflammation et de l'infiltration cellulaire dans les poumons des souris déficientes. Cette inflammation excessive est caractérisée par une augmentation de production du TNF-a et de iNOS dans les poumons. En conclusion, nos résultats révèlent une nouvelle voie moléculaire par laquelle les lectines peuvent moduler l'équilibre entre l'inflammation induite par l'infection et le contrôle du pathogène par l'intermédiaire de la modulation de la signalisation relative à l'IFN de type I dans les cellules dendritiques. / Tuberculosis (TB) is a wide-spread disease which causes the death of more than one million of people around the world each year. This represents a really harmfull healthcare and new drugs and treatments are always in development to better fight this destructive illness. In this context, it is crucial to understand the relation between the etiological agent, Mycobacterium tuberculosis (Mtb) and the immune system. Mycobacteria are recovered by some glycolipid structure which could be recognized by specific receptor called C-Type Lectin. Here we investigated the role of two recently highlights C-type lectins which haven't been studied in a tuberculosis context, CL-LK (Collectin Liver Kidney) and DCIR (Dendritic Cell (DC) ImmunoReceptor). In the recent years, novel soluble lectins were identified and belong these; CL-K1 (Collectin Kidney 1) was identified by a glycan array as a potential receptor in the sugar complex recognition of M.tb. In blood, CL-K1 is linked with another soluble lectin called CL-L1 (Collectin Liver 1) and form a complex CL-LK molecule. With some in vitro experiment, notably with biochemistry approach and cytometer analysis, we were able to confirm that CL-LK can bind Mtb and more particularly the mannose residue presents on the Lipoarabinomannan, a major constituent of the mycomembrane. Mice deficient in CL-K1, one of the CL-LK subunits, do not display altered susceptibility to Mtb. However, we found that the amount of CL-LK in the serum of patients with active TB is reduced, compared to that in controls, and correlates inversely to the magnitude of the immune response to the pathogen. These findings indicate that CL-LK might be of interest for future diagnostic and treatment monitoring purposes. In a second part of this thesis, we have focused our interest on the C-Type lectin DCIR in immunity to the tuberculosis agent, Mtb. DCIR is expressed in pulmonary lesions in Mtb-infected non-human primates during both symptomless infection and active TB disease. In vitro, global gene expression profiling coupled to RT-qPCR validation revealed that upon Mtb infection, the expression of a number of interferon (IFN)-responsive genes was impaired in DCIR-deficient murine bone marrow-derived DCs, compared to in wild-type cells. This inhibition correlated with an excessive phosphorylation of Src homology 2 domain tyrosine phosphatase (SHP)2 in DCIR-KO cells, followed by a subsequent dephosphorylation of Signal transducer and activator of transcription1(STAT1) which is crucially involved in the regulation of the type I IFN.Type I IFNs are known to inhibit interleukin (IL)-12 production in DCs, and indeed, we found that impaired IFN signaling in DCIR-deficient DCs was associated with an increased production of IL-12p70 and an increased ability of Mtb-infected cells to stimulate IFN?-producing Th1 lymphocyte proliferation. DCIR-deficient mice controlled Mtb infection better than wild-type animals, which correlated with an increased production of IL-12p70, an increased proliferation of Th1 lymphocytes, and an increased inflammation and cell infiltration in the lungs of DCIR-KO animals. This excessive inflammation is characterized by an increased production of tumor necrosis factor alpha (TNFa) and inducible nitric oxide synthase (iNOS) in the lungs. Taken together, our results reveal a novel pathway by which a C-Type lectin modulates the equilibrium between infection-driven inflammation and pathogen's control through sustaining type I IFN signaling in DCs.
|
493 |
Moyens modernes du diagnostic de la tuberculose pulmonaireEl Khechine, Amel 20 June 2011 (has links)
Les méthodes pour le diagnostic des infections à mycobactéries sont restées pratiquement inchangées pendant des décennies et n'auraient probablement pas progressé sans la réémergence inattendue de la tuberculose (TB) au cours des vingt dernières années du 20ème siècle. Le diagnostic de laboratoire de la tuberculose pulmonaire repose principalement sur la détection des organismes du complexe Mycobacterium tuberculosis (MTC) dans les prélèvements respiratoires par leur isolement et identification ou par les méthodes moléculaires. Pour les patients qui n’expectorent pas, des échantillons du tractus respiratoire peuvent être obtenus par des procédures invasives. En nous basant sur la survie connue de MTC dans le liquide gastrique, nous avons considéré que les MTC devraient également être détectables dans les selles. Nous avons recherché des MTC en parallèle dans des échantillons de tractus respiratoire et dans les selles récoltés des mêmes patients. Mycobacterium tuberculosis a été détecté après décontamination à la chlorhexidine dans des cultures sur des milieux à base d'œuf et par l'examen direct microscopique après coloration de Ziehl-Neelsen. Après la mise au point d’une technique originale d’extraction de l’ADN total à partir des selles, nous avons utilisé la détection de M. tuberculosis par PCR en temps réel en duplex utilisant le gène IS6110 comme cible moléculaire et un contrôle interne de présence d’inhibiteurs de la PCR. Ces travaux mettent en évidence l’intérêt et la sensibilité de l’analyse des selles pour le diagnostic de la tuberculose pulmonaire. Cette technique est aujourd’hui utilisée dans notre laboratoire en routine et est en cours d’évaluation par d’autres équipes.Actuellement, l'identification des mycobactéries basée sur l’analyse des caractéristiques biochimiques (test à l’uréase, test de la nitrate réductase, test de la résistance à la pyrazinamide (pza), test de la sensibilité, test de la résistance à la thiophen-2-carboxylic acid hydrazide (TCH) etc …) est le plus souvent remplacée par des méthodes de biologie moléculaire dont l’amplification par PCR d'un gène spécifique. Ces méthodes sont laborieuses et peuvent exiger un degré d'expertise élevé. Afin de simplifier l'identification précise des isolats de mycobactéries en laboratoire de routine, après avoir vérifié l’inactivation des MTC par la chaleur et l’éthanol pour pouvoir travailler hors du laboratoire P3, nous avons mis au point les conditions pour l'utilisation de la spectrométrie de masse « matrix-assisted laser desorption and ionisation-time-of-flight» (MALDI-TOF-MS) en association avec un logiciel bioinformatique spécifique, comme outil d’identification et de différenciation entre les membres du complexe MTC, du complexe Mycobacterium avium et les autres mycobactéries non-tuberculeuses. Nous avons ensuite appliqué cette technique afin d’identifier les mycobactéries à partir du milieu liquide Middlebrook 7H10 utilisé dans une étuve automatisée. L’identification des mycobactéries isolées dans notre laboratoire, est maintenant réalisée en routine par MALDI-TOF-MS. L’ensemble de ces travaux contribue à améliorer le diagnostic de routine de la tuberculose pulmonaire et les techniques mises au point sont utilisées en routine dans notre laboratoire, en particulier dans le cadre d’un « kit tuberculose ». / The diagnosis of mycobacterial infections remained practically unchanged during numerous decades and would not probably have progressed of the whole without the unexpected re-emergence of the tuberculosis (TB) during the last twenty years of the 20th century.The diagnosis of laboratory of pulmonary tuberculosis is mainly based on the detection of microorganisms of the Mycobacterium tuberculosis complex (MTC) in the respiratory specimens. For the patients who do not expectorate, samples of the respiratory tract can be only obtained according to invasive procedures. Based on the survival known for MTC organisms in the gastric liquid, we considered that MTC organisms would be detectable also in samples of stools. We compared the presence of bodies MTC in samples of respiratory tract and the specimens of stools collected from the same patients. MTC was detected in cultures on egg-based media after appropriate decontamination using the chlorhexidine and by the microscopic examination after Ziehl-Neelsen staining. After the set on of an original protocol of the total DNA extraction from stools, we were able to use by the detection with the real-time PCR of IS6110 using internal controls as PCR inhibitor control. This protocol illustrate the utility of stool analysis for the diagnosis of pulmonary tuberculosis, this technique is actually used in routine in our laboratory, it is also under investigation by other research teams.Phenotypic identification of mycobacteria based on the analysis of biochemical pattern (urase test, nitrate reductase test, resistance to pyrazinamide (pza) test, susceptibility to thiophen-2-carboxylic acid hydrazide (TCH) test, etc …) is more often replaced by molecular methods using DNA, including the development by PCR of a specific gene. These methods are generally laborious and can require a considerable degree of expertise. To simplify the identification specifies isolates of mycobacteria routinely in the laboratory, we estimated the use of the mass spectrometry "matrix-assisted laser desorption and ionization-time-of-flight" (MALDI-TOF MS) in association with a specific bioIT software, was capable of identifying and of distinguishing between the members of Mycobacterium tuberculosis complex, Mycobacterium avium complex and the non- tuberculosis mycobacteria. We verified the MTC inactivation by heating or by ethanol allowing the analysis of the inactivated MTC out of the P3 laboratory; we studied the cost-effectiveness of this method from the blood solid media by extrapolating this approach in the emergent countries. We then applied the same method to identify mycobacteria from Middlebrook 7H10 liquid media used in an automated oven. Identification of cultured Mycobacteria is now done in routine in our laboratory by MALDI-TOF-MS. These data contribute in improving the routine diagnosis of pulmonary tuberculosis and this protocol is then used routinely in our laboratory, particularly with the “kit de tuberculose” we set on.
|
494 |
Molecular characterization of Mycobacterium tuberculosis complex and prevalence of nontuberculous mycobacteria and other potential pathogenic bacteria from Tubercolisis suspents in Northeastern, TanzaniaHoza, Abubakar Shaaban 06 September 2016 (has links)
Molecular typing is increasingly essential to tuberculosis (TB) control programmes, providing public health practitioners with a tool to characterize transmission patterns, track the emergence and spread of strains of M. tuberculosis complex (MTC) in populations. While molecular typing is already used extensively as a tool for TB control in many developed settings across the globe, its use in resource-poor settings is still limited. Moreover, information on the role, contribution and burden of nontuberculous mycobacteria (NTM) and other pathogens in aetiology of TB-like syndromes is also lacking in such settings.
The broad objective of this dissertation was to determine the genetic diversity of MTC and their drug resistance profiles as well as the prevalence of NTM and other potentially pathogenic bacteria among TB suspects in Northeastern, Tanzania in order to generate insights that may inform the design of a rational TB control programmes.
A total of 18 distinct spoligotypes were identified in this study area, with CAS1-KILI and EAI8 being the most predominant families. Major lineages prediction by conformal Bayesian network (CBN) revealed that 70% of TB infections in this area is due to modern lineages, whereas 30% of TB infections is due to the ancestral lineages mainly of Indo-oceanic lineage.
The study also revealed that the overall proportions of any drug resistance and MDR-TB were 12.7% and 6.3% respectively. With the prevalence of any drug resistance and MDR-TB among new cases being 11.4% and 4.3% respectively, among previously, treated cases were 22.2%. The prevalence of NTM was found to be 9.7 %, with HIV being a significant predictor of NTM detection (P < 0.001). Four out of 30 patients with NTM diagnosed by culture received 1st line anti-TB treatment suggesting that a proportion of patients diagnosed by smear microscopy (4/65, 6.2%) were mistreated as TB patients. Our findings further showed that 17 (4.6%) out of 372 TB suspects were due to pulmonary nocardiosis.
Overall this dissertation has revealed that TB is still a major problem in Tanga and is characterized by a diverse array of MTB strains. Additionally, modern MTB strains contribute significantly to TB infections in this area. High proportions of anti-TB drug resistance among new treated cases observed suggest that more efforts need to be done to identify individual cases at facility level for improved TB control programmes. Inefficient screening of TB patients and a prevalent increase of NTM may contribute to both unrealistic and mismanagement of TB cases. A diverse array of pathogenic Nocardia species among TB suspects further indicates that they are likely cause of human disease in this population.
Therefore, need to integrate NTM and pathogens causing TB-like syndromes in diagnosis and management of TB is urgent. Results of these investigations contribute to the understanding of the dynamics of TB transmission in resource poor settings of Tanzania and highlight key factors that should be considered in the development of rational approaches to design effective TB prevention and control programmes in the country.
|
495 |
Les infections à mycobactéries du complexe Mycobacterium tuberculosis à Libreville : profil des résistances aux antibiotiques et diversité génétique / Mycobacterium infections of the Mycobacterium tuberculosis complex in Libreville : profile of resistance to antibiotics and genetic diversityAlame Emane, Amel Kevin 15 November 2016 (has links)
Le phénomène émergent de la tuberculose multirésistante et ultrarésistante est un problème de santé publique à l’échelle mondiale. Dans les pays en développement, ce problème est accru du fait que les laboratoires de diagnostic de la tuberculose manquent d’équipement et d’outils de diagnostics pour identifier ces cas pour prescrire une chimiothérapie adaptée. La première partie de ce travail de doctorat a permis à travers le séquençage du locus pncA, de mettre en évidence que la résistance au Pyrazinamide survient généralement et de manière significative lorsque la souche est multirésistante, c’est-à-dire après l’acquisition de la résistance à la Rifampicine et à l’Isoniazide. Le pourcentage des souches résistantes au PZA est même plus élevé chez les souches MDR résistantes aux FQs. Dans la seconde partie de l’étude, nous proposons une méthode alternative à la culture de bacilles dans un environnement confiné de type P3. À partir d’échantillons cliniques non cultivés (expectoration) et grâce au GeneXpert MTB/RIF, au séquençage de gènes et au spoligotypage, nous avons pu identifier 19 souches multirésistantes, une transmission active de souches sensibles appartenant aux clades LAM10, T1, MANU, H3 et enfin une épidémie sous-jacente de 5 souches Beijing multirésistantes. / The emerging phenomenon of the MDR and XDR-TB is a worldwide public health issue. In developing countries, this problem is amplified due to the fact that TB diagnostic laboratories lack equipment and diagnostic tools to identify these cases and therefore prescribe appropriate chemotherapy. In the first part of this doctoral work, the sequencing of the pncA gene allowed us to show that the resistance to Pyrazinamide occurs significantly when the strain is MDR, corresponding to the acquisition of resistance to Rifampicin and Isoniazid; and that after the acquisition of Fluoroquinolones and to injectable antibiotics of second line (Amykacine, Kanamycine, Capreomycine) resistance by MDR strains, this rate increases even more. In the second part of the study, we propose an alternative method to the culture of bacilli in a BSL3 confined environment. From uncultivated clinical samples (sputum) and through GeneXpert MTB/RIF, sequencing of genes and spoligotyping, we identified 19 MDR strains, active transmission of sensitive strains belonging to clades LAM10, T1, MANU, H3 and finally as well as an underlying epidemic of 5 Beijing MDR strains.In the first study, 272 retrospective samples of Mycobacterium tuberculosis isolates were selected from two large cosmopolitan cities: Northern Paris (Bichat-Claude Bernard Hospital, 101 strains) and Southwest of Shanghai (Songjiang district, 171 Strains). These strains were selected according to their known phenotypic sensitivity to Rifampicin (RIF) and Isoniazid (INH). These phenotypic resistances were confirmed by the HAIN genotype analysis tools MTBDRplus and by the sequencing of the rpoB and katG/inhA genes. To determine the extensively drug resistance strains (XDR), we sequenced the gyrA/gyrB and rrs genes to identify genetic mutations associated with resistance to Fluoroquinolones (FQs) and second-line injectable antibiotics: Amikacin (AMK)-Kanamycin ( KAN)-Capreomycin (CAP), respectively. Finally, we sequenced the pncA gene of all isolates to identify the genetic mutations associated with resistance to Pyrazinamide (PZA). The strains were genotyped by spoligotyping and MIRU-VNTR.In the second study, from October 2014 to February 2015, 159 morning sputum samples with smear-positive smear after Ziehl-Neelsen staining were collected at the three main diagnostic laboratories for tuberculosis in Libreville, Gabon. These clinical samples were transported to the National Laboratory of Public Health in Libreville for analysis with the GeneXpert MTB/RIF automaton to confirm the microscopic diagnosis and to determine the resistance of bacilli to Rifampicin. Of the 159 samples, 29 samples had a sputum volume less than 1 ml, the minimum required according to the manufacturer's recommendations. For the 130 sputum samples analyzed by the GeneXpert automaton, 375 μl of the remaining GeneXpert solution not introduced into the cartridge was introduced into a 50 ml conical tube containing 25 ml of phosphate buffer (autoclaved solution) to neutralize the pH of the GeneXpert solution. The conical tube is centrifuged for 15 minutes at 4,500 rpm, the pellet is taken up in 100 μl of TE and then transferred to a 100 μl microtube which is subsequently heated for 30 minutes at 90°C. After a cycle of freezing (-40 ° C. for 1 h)-defrosting, the microtube is briefly centrifuged and the supernatant is transferred to a new microtube. From this new microtube we amplified by PCR and then sequenced the rpoB, katG/inhA, pncA, gyrA, rrs and rpsL genes to identify mutations associated with resistance to Rifampicin, Isoniazid, Pyrazinamide, Fluoroquinolones, Antibiotics in second lines: Amikacin-Kanamycin-Capreomycin and Streptomycin (SM), respectively. All the samples were genotyped by the multiplexed spoligotyping applied to the Luminex MagPix.
|
496 |
Analysis and application of evolutionary markers in the epidemiology of Mycobacterium tuberculosisVan der Spuy, Gian Dreyer 12 1900 (has links)
Thesis (PhD (Biomedical Sciences. Molecular Biology and Human Genetics))--Stellenbosch University, 2008. / This series of studies includes both methodological analyses, aimed at furthering our understanding of, and improving the tools used in molecular epidemiology, and investigative projects which have used these tools to add to our knowledge of the M. tuberculosis epidemic.
Using serial isolates from tuberculosis patients, we have investigated the evolutionary rate of the
IS6110 RFLP pattern. In accordance with other studies, we determined a ½-life for this
epidemiological marker of 10.69 years, confirming its appropriateness for this purpose. We also
identified an initial, much higher apparent rate which we proposed was the result of pre-diagnostic
evolution. In support of this, our investigations in the context of household transmission of M.
tuberculosis revealed that IS6110-based evolution is closely associated with transmission of the
organism, resulting in a strain population rate of change of 2.9% per annum.
To accommodate evolution within estimates of transmission, we proposed that calculations
incorporate the concept of Nearest Genetic Distance (cases most similar in RFLP pattern and most closely associated in time). We used this to create transmission chains which allowed for limited evolution of the IS6110 marker. As a result, in our study community, the estimated level of disease attributable to ongoing transmission was increased to between 73 and 88% depending on the Genetic Distance allowed.
We identified the duration of a study as a further source of under-estimation of transmission. This results from the artefactual abridgement of transmission chains caused by the loss of cases at the temporal boundaries of a study. Using both real and simulated data, we showed that viewing a 12-year study through shorter window periods dramatically lowered estimates of transmission. This effect
was negatively correlated with the size of a cluster.
Various combinations of MIRU-VNTR loci have been proposed as an alternative epidemiological
marker. Our investigations showed that, while this method yielded estimates of transmission similar to those of IS6110, there was discordance between the two markers in the epidemiological linking of cases as a result of their independent evolution. Attempting to compensate for this by allowing for evolution during transmission improved the performance of IS6110, but generally had a deleterious effect of that of MIRU-VNTR. However, this marker remains a valuable tool for higher phylogenetic analysis and we used it to demonstrate a correlation between sublineages of the Beijing clade and the regions in which they are found. We proposed that, either the host population had selected for a particular sublineage, or that specific sublineages had adapted to be more successful in particular
human populations.
We further explored the dynamics of the epidemic over a 12-year period in terms of the five
predominant M. tuberculosis clades. We found that, while four of these clades remained relatively stable, the incidence of cases from the Beijing clade increased exponentially. This growth was attributed to drug-sensitive cases although drug-resistant Beijing cases also appeared to be more successful than their non-Beijing counterparts. Possible factors contributing to this clade’s success were a greater proportion of positive sputum smears and a lower rate of successful treatment.
|
497 |
Large-Scale Structural Analysis of Protein-ligand Interactions : Exploring New Paradigms in Anti-Tubercular Drug DiscoveryAnand, Praveen January 2015 (has links) (PDF)
BIOLOGICAL processes are governed through specific interactions of macromolecules. The three-dimensional structural information of the macromolecules is necessary to understand the basis of molecular recognition. A large number of protein structures have been determined at a high resolution using various experimental techniques such as X-ray crystallography, NMR, electron microscopy and made publicly available through the Protein Data Bank. In the recent years, comprehending function by studying a large number of related proteins is proving to be very fruitful for understanding their biological role and gaining mechanistic insights into molecular recognition. Availability of large-scale structural data has indeed made this task of predicting the protein function from three-dimensional structure, feasible. Structural bioinformatics, a branch of bioinformatics, has evolved into a separate discipline to rationalize and classify the information present in three-dimensional structures and derive meaningful biological insights. This has provided a better understanding of biological processes at a higher resolution in several cases. Most of the structural bioinformatics approaches so far, have focused on fold-level analysis of proteins and their relationship to sequences. It has long been recognized that sequence-fold or fold-function relationships are highly complex. Information on one aspect cannot be readily extrapolated to the other. To a significant extent, this can be overcome by understanding similarities in proteins by comparing their binding site structures. In this thesis, the primary focus is on analyzing the small-molecule ligand binding sites in protein structures, as most of the biological processes ranging from enzyme catalysis to complex signaling cascades are mediated through protein-ligand interactions. Moreover, given that the precise geometry and the chemical properties of the residues at the ligand binding sites dictate the molecular recognition capabilities, focusing on these sites at the structural level, is likely to yield more direct insights on protein function.
The study of binding sites at the structural level poses several problems mainly because the residues at the site may be sequentially discontinuous but spatially proximal. Further, the order of the binding site residues in primary sequence, in most of cases has no significance for ligand binding. Compounding these difficulties are additional factors such as, non-uniform contribution to binding from different residues, and size-variations in binding sites even across closely related proteins. As a result, methods available to study ligand-binding sites in proteins, especially on a large-scale are limited, warranting exploration of new approaches. In the present work, new methods and tools have been developed to address some of these challenges in binding site analysis. First, a novel tool for site-based function annotation of protein structures, called PocketAnnotate was developed ( http://proline.biochem.iisc.ernet. in/pocketannotate/). PocketAnnotate, detects the putative binding sites from a given protein structure and compares them to known binding sites in PDB to derive functional annotation in terms of ligand association. Since the tool derives functional annotation at the level of binding sites, it has an advantage over other methods that solely utilize fold or sequence information. This becomes even more important for cases where there is no detectable homology with entries in existing databases, as Pocket Annotate does not depend on evolutionary based information for annotation.
Second, a web-accessible tool for in silico almandine scanning mutations of binding site residues called ABS-Scan has been developed ( http://proline.biochem.iisc.ernet.in/abscan/). This tool helps in assessing the contribution of the individual residues of binding sites in the protein towards ligand recognition. All residues, one at a time, in a binding site are mutated systematically to an alanine and the ability of the corresponding mutant to bind a given ligand is analyzed. The contribution of each residue towards ligand binding is calculated through a G value derived by comparing the binding affinity to the wild-type protein-ligand complex.
Third, a database called Protein-Ligand Interaction Clusters (PLIC) has been developed to identify and analyze the information of similarity across binding sites in PDB, which has been provided in the form of a web-accessible database ( http://proline.biochem.iisc.ernet/ PLIC). Protein-ligand interactions are primarily explored using three different computational approaches - (i) binding site characteristics including pocket shape, nature of residues and interaction profiles with different kinds of chemical probes, (ii) atomic contacts between protein and ligands (iii) binding energetics involved in interactions derived from scoring functions developed for docking. The information on variations in these features derived from different computational tools is also included in the database for enabling the characterization of the binding sites. As a case study to demonstrate the usefulness of these tools, they have been applied to decipher the complexity of S-adenosyl methionine interactions with the protein. Around 1,213 binding sites of SAM or SAM-like compounds could be extracted from the PLIC database. The SAM or SAM-like compounds were observed to interact with ∼18 different protein-fold types. The variations in different protein-ligand contacts across fold types were analyzed. The fold-specific interaction properties and contribution of individual residues towards SAM binding are identified. The tools developed and example analyses using them are described in Chapter 2.
Chapter 3 describes a large-scale pocketome analysis from structural complexes in PDB, in an effort to characterize the known pocket space of protein-ligand interactions. Tools devel-opted as described in Chapter 2 are used for this. A set of 84,846 binding sites compiled from PDB, have been comprehensively analyzed with an objective of obtaining (a) classification of binding sites, (b) sequence-fold-site relationships among proteins, (c) a minimal set of physicochemical attributes sufficient to explain ligand recognition specificity and (d) site-type specific signatures in terms of physicochemical features. A new method to describe binding sites was developed in the form of BScIds such that the structural fold information is well captured. Binding sites and similarities among them were abstracted in the form of networks where each node represents a binding site and an edge between two nodes represents significant similarity between the sites at the structural level. Pocketome networks were constructed from the large-scale information on protein-ligand interactions in the PLIC database. The large pocketome network was then studied to derive relationships between protein folds and chemical entities they interact with. A classification of the binding pockets was achieved by analyzing the pocketome network using graph theoretical approaches combined with clustering methods. 10,858 clusters were identified from the network, each indicating a site-type. Thus, it can be said that there are about 10,858 site-types. Classification of ligand associations into specific site-types helps greatly in resolving the complex relationships by yielding specific site-type ligand associations. The observed classification was further probed to understand the basis of ligand recognition by representing the pockets through feature vectors. These features capture a wide range of physicochemical properties that can be used to derive site-type specific signatures and explore the pocket-space of protein-ligand interactions. A principal component analysis of these features reveals that binding site feature space is continuous in the entire PDB and minor changes in specific features can give rise to significant differences in ligand specificity, consequently defining their distinct functional roles. The weights were also derived for these features through the use of different information theoretic approaches to explain the multiple-specificity of protein-ligand interactions. Analysis of binding sites arising from contribution of residues from different protein fold-types revealed increasing diversity of physicochemical properties at the site, supporting the hypothesis that combination of folds could give rise to new binding sites.
Given that a finer appreciation of the molecular mechanisms within the cell is possible only with the structural information, the next objective was to explore if a structural view of an entire proteome can be obtained and if a pocketome could be constructed and analyzed. With this in mind, the causative agent of tuberculosis - Mycobacterium tuberculosis (Mtb) was chosen. Mtb is also being studied in the laboratory from a systems biology perspective, which enabled exploration of how systems and the structural perspectives could be combined and applied for drug discovery. Chapters 4 to 6 describe this effort.
The genome sequence of Mycobacterium tuberculosis (Mtb) H37Rv, indicates the presence of ∼4,000 protein coding genes, of which experimentally determined structures are available for ∼300 proteins. Further, advances in homology modeling methods have made it feasible to obtain structural models for many more proteins in the proteome. Chapter 4 describes the efforts for obtaining the Mtb structural proteome, through which the three-dimensional struc-tures were derived for ∼70% of the proteins in the genome. Functional annotation of each protein was derived based on fold-based functional assignments, binding-site comparisons and consequent ligand associations. PocketAnnotate, a site-based function annotation pipeline was utilized for this purpose and is described in Chapter 2. Besides these, the annotation covers detection of various sequence and sub-structural motifs and quaternary structure predictions based on the corresponding templates. The study provides a unique opportunity to obtain a global perspective of the fold distribution in the genome. The annotation indicates that cellular metabolism can be achieved with only 219 unique folds. New insights about the folds that predominate in the genome, as well as the fold-combinations that make up multi-domain proteins are also obtained. 1,728 binding pockets have been associated with ligands through binding site identification and sub-structure similarity analyses, yielding a list of ligands that can participate in various biochemical events in the mycobacterial cell. A web-accessible database MtbStructuralproteome has been developed to make the data and the analyses available to the community, ( http://proline.physics.iisc.ernet.in/Tbstructuralannotation). The resource, being one of the first to be based on structure-based functional annotations at a genome scale, is expected to be useful for better understanding of tuberculosis and for application in drug discovery. The reported annotation pipeline is fairly generic and can be applied to other genomes as well.
Chapter 5 describes the characterization of the Mtb pocketome. For the structural models of the Mtb proteome described in chapter 4, a genome-scale binding site prediction exercise was carried out using three different computational methods and subsequently obtaining consensus predictions. The three methods were independent and were based on considering geometry, inter-molecular energies with probes and sequence conservations in evolutionarily related proteins respectively. In all, 13,858 consensus binding pockets were predicted in 2,877 proteins. The pocket space within Mtb was then explored through systematic all-pair comparisons of binding sites. The number of site-types within Mtb was found to be 6,584, as compared to the ∼400 structural folds and 1,831 unique sequence families. This reveals that the pocket space is larger than the sequence or fold-space, suggesting that variations at the site-level contribute significantly to functional repertoire of the organism. By comparing the pockets with the PDB sites enclosing known ligands, around 6906 binding sites were observed to exhibit significant similarity in the entire pockets to some or the other known binding site in PDB. 1,213 metabolites could be mapped onto 665 enzymes covering most of the metabolic pathways. The identified ligands serve as a predicted metabolome for unit abundances of the proteins. A list of proteins containing unique pockets is also identified. The binding pockets, similarities they share within Mtb and the ligands mapped onto them are all made available in a web-accessible database at http://proline.biochem.iisc.ernet.in/mtbpocketome/.
The availability of structural information of the pocketome at a genome-scale opens up several opportunities in drug discovery. They can be directly applied for understanding mechanism of drug action, predicting adverse effects and pharmacodynamics of a drug. Moreover, it enables exploration of new ideas in drug discovery. Polypharmacology is a new concept that aims at modulating multiple drug targets through a single chemical entity. Currently, there are no established approaches to either select appropriate target sets or design polypharmacological drugs. In this study, a structural-proteomics approach is explored to first characterize the pocketome and then utilize it to identify similar binding sites. The knowledge of similarity relationships between the binding sites within the genome can be used in identifying possible polypharmacological drug targets. A pocket similarity based clustering of binding site residues resulted in identification of binding site sets, each having a theoretical potential to interact with a common ligand. A polypharmacological index was formulated to rank targets by incorporating a measure of drug ability and similarity to other pockets within the proteome. By comparing with known drug binding sites from databases such as the Drug Bank, the study has yielded a ready shortlist that includes sets of promising drug targets with polypharmacological possibilities and at the same time has identified possible drug candidates either directly for repurposing or at the least as significant lead clues that can be used to design new drug molecules against the entire group of proteins in each set. This analysis presents a rational approach to identify targets with polypharmacological potential, clues about lead compounds and a list of candidates for drug repurposing.
This thesis demonstrates the feasibility of utilizing the structural bioinformatics approaches at a genome-scale. The tools developed for analyzing large-scale data on protein-ligand inter-actions could be applied to characterize the pocket-space of protein-ligand interactions. The network theory approaches applied in this work, make large-scale data tractable and enable binding-site typing. The binding site analysis at a genome-scale for Mtb is first of its kind and has provided novel insights into the pocket space. The binding site analysis performed on a genome-scale for Mtb provided an opportunity to rationalize the polypharmacological target selection and explore drugs for repurposing in TB. In the larger context, structural modelling of a proteome, mapping the small-molecule binding space in it and understanding the determinants of small-molecule recognition forms a major step in defining a proteome at higher resolution. This in turn will serve as a valuable input towards the emerging field of structural-systems biology, which seeks to understand the biological models at a systems level without compromising on the resolution of the study.
|
498 |
Reação imunoenzimática (ELISA) para detecção de imunoglobulina M, imunoglobulina G e imunoglobulina A contra a proteína rHsp-X (Rv 2031c)de Mycobacterium tuberculosis em pacientes com tuberculose pleural / Linked immunosorbent assay (ELISA) for detection of immunoglobulin M, immunoglobulin G and immunoglobulin A against the protein rHsp-X (Rv2031c) of Mycobacterium tuberculosis in patients with pleural tuberculosisLIMONGI, Loanda Carvalho Sant'ana 18 December 2009 (has links)
Made available in DSpace on 2014-07-29T15:30:34Z (GMT). No. of bitstreams: 1
Dissertacao Loanda Carvalho S Limongi.pdf: 1004813 bytes, checksum: 09f423fef50cc45223e734df788a0c39 (MD5)
Previous issue date: 2009-12-18 / Pleural tuberculosis (TBP) has often spontaneous resolution, even without
treatment. However, the lack of proper diagnosis and treatment can lead to the
occurrence of pulmonary and/or extra-pulmonary tuberculosis in 65% of the
cases, in the five years subsequent. The objective of this study was to
evaluate the effectiveness of the recombinant Hsp-X antigen (rHsp-X) in
an enzyme immunoassay for determining the presence of TBP in patients
with pleural effusion. For this study we used 132 samples of serum and
pleural fluid (PF) from patients with pleural effusion. Of these, 97 samples
were from TBP patients and 35 patients with diseases other than
tuberculosis (NTBP) (28 patients with metastatic cancer, 1 patient with
congestive heart failure, 2 patients whit liver failure, 1 patient with
systemic lupus erythematosus and 3 patients with parapneumonic
effusion). The IgM levels of PF were higher in patients with PTB than
NTBP, the sensitivity and specificity of the ELISA for the PF was 42% and
83%, respectively. Testing for IgG from the serum and the PF against the
recombinant antigen Hsp-X were not effective in discriminating TB
patients from other diseases, the sensitivity was found to be 13% and 16%
using serum and LP, respectively, with the same specificity of 83%. TBP
patients presented higher levels of IgA specific for the rHSP-X than NTBP,
the IgA ELISA using PF presented better sensitivity (65%) than using
serum (39%), while the IgA ELISA for both types of samples presented the
same specificity (83%). In conclusion, the recognition of Mycobacterium
tuberculosis rHsp-X by IgA antibodies from the PF of patients with TBP
reveals its possible role in the development of a diagnostic test for
additional cases of TBP. Further studies must be conducted to confirm
this hypothesis. / A tuberculose pleural (TBP) frequentemente tem resolução espontânea,
mesmo sem tratamento. No entanto, a ausência de diagnóstico e tratamento
pode levar, nos cinco anos subseqüentes, à ocorrência de tuberculose
pulmonar e/ ou extrapulmonar em 65% dos casos. O objetivo deste estudo foi
avaliar a eficácia da utilização do antígeno Hsp-X em um ensaio
imunoenzimático para determinação da presença de TBP em indivíduos com
derrame pleural. Para o estudo foram utilizadas 132 amostras de soro e líquido
pleural (LP) de pacientes com derrame pleural. Destas, 97 amostras eram de
pacientes TBP e 35 de pacientes com outras doenças não tuberculosas
(NTBP) (28 pacientes por câncer metastático, 1 pacientes por insuficiência
cardíaca congestiva, 2 paciente por insuficiência hepática, 1 paciente por lúpus
eritematoso sistêmico e 3 pacientes por derrames parapneumônicos). Os níveis
de IgM do LP foram mais elevados nos pacientes com TBP do que os NTBP, a
sensibilidade do ELISA para do LP de 42%, para a especificidade de 83%. Os
ensaios para pesquisa de IgG, do soro e do LP, contra o antígeno Hsp-X não
foram eficazes em discriminar pacientes com TBP de outras doenças, a
sensibilidade encontrada foi de 13% e 16%, utilizando o soro e o LP,
respectivamente, para a mesma especificidade de 83%. A densidade óptica
dos ensaios para pesquisa de IgA, específicos para o antígeno rHsp-X, foi mais
elevada nos pacientes TBP do que os NTBP, o ELISA com a IgA do LP foi
melhor que o ELISA do soro, a sensibilidade foi de 65% e 39%,
respectivamente, para a mesma especificidade de 83%. Concluímos que o
reconhecimento de Hsp-X recombinante de Mycobacterium tuberculosis pelos
anticorpos IgA do LP de pacientes com TBP indicam que esse antígeno poderá
ser utilizado para o desenvolvimento de um teste de diagnóstico complementar
para casos de TBP. Estudos adicionais precisam ser realizados para confirmar
tal hipótese.
|
499 |
Transcription Initiation and its Regulation in Mycobacterium TuberculosisTare, Priyanka January 2014 (has links) (PDF)
The ability to fine-tune gene-expression in the adverse conditions during pre and post infectious stages has contributed in no small measure to the success of Mycobacterium tuberculosis as the deadly pathogen. Multiple sigma factors, transcription regulators, and diverse two component systemshave facilitated tailoring the metabolic pathways to meet the challenges faced by the pathogen. Over the last decade, studies have been initiated to understand the various facets of transcription in mycobacteria. Although not as extensive as the work in other model systems, such as Escherichia coli and eukaryotes, it is evident from these initial studies that the machinery is conserved,yetmany aspects of transcription and its regulation seem to be different in mycobacteria.The work presented in the thesis deals with some of the steps in the process, primarily initiation in the context of the distinct physiology of M. tuberculosis. The detailed kinetic and equilibrium study of a few selected promoters of M. tuberculosis viz.PgyrB1, PgyrR, PrrnPCL1 and PmetU is described in Chapter 2.Different stages of transcription initiation that have been analyzed include promoter specific binding of RNAP, isomerization, abortive initiation and promoter clearance.The equilibrium binding and kinetic studies of various steps reveal distinct rate limiting events for each of the promoter, which also differed markedly in their characteristics from the respective promoters of Mycobacterium smegmatis. In addition, a novel aspect of the transcription initiation at the gyr promoter was unraveled. The marked differences in the transcription initiation pathway seen with rrn and gyr promoters of M. smegmatis and M. tuberculosis suggest that such species specific differences in the regulation of expression of the crucial housekeeping genes could be one of the key determinants contributing to the differences in growth rate and lifestyle of the two organisms. In Chapter 3, the mechanism of growth phase dependent control (GPDC) at a few of the M. tuberculosis promoters has been investigated. The experiments described in the chapter are carried out to demonstrate a different pattern of interaction between the promoters and sigma A (SigA) of M. tuberculosis to facilitate the iNTPs and pppGpp mediated regulation. Instead of cytosine and methionine, thymine at three nucleotides downstream to -10 element and leucine232 in SigA are found to be essential for iNTPs and pppGpp mediated response at the rrn and gyr promoters of the organism. The specificity of the interaction is substantiated by mutational replacements, either in the discriminator or in SigA, which abolish the nucleotide mediated regulation in vitro or in vivo. In chapter 4, the long standing hypothesis that deals with interdependence of the transcription elongation kinetics and the growth rates has been addressed. Previous studies suggest that the rate of synthesis of the key molecules in cells affects the growth kinetics. In order to validate, the kinetics of elongation of RNAPs from M. tuberculosis, M. smegmatis and E. coli whose growth rates vary from very slow to fast is measured. Surface Plasmon Resonance (SPR) is used to monitor the transcription in real time and kinetic equations are applied to calculate the elongation rates. Further, the effects of the composition of the template DNA on the elongation rates of RNAP from E. coli and M. smegmatis, whose genomes show difference in the GC content are explored. The results obtained from the analysis support the hypothesis and also reveal the effect of template composition on elongation rates of RNAP.
|
500 |
Molecular Characterisation Of Mycobacterium Tuberculosis Fic Protein And Its Gene And Identification And Characterisation Of A Novel Functional Interaction Between FtsZ And NDK in MycobacteriaMishra, Saurabh 07 1900 (has links) (PDF)
Living organisms employ different kinds of mechanisms, to regulate the functions of genes or their products, which may help in maintaining homeostasis inside the cell or may help in fighting hostile environment in the case of pathogenic organisms. These mechanisms act at the transcriptional, post-transcriptional, translational, and post-translational levels. In order to understand the physiology of an organism, it is essential to obtain an in-depth knowledge of such mechanisms, in which several proteins participate in interlinked pathways. In this regard, the present study focuses on two such proteins: (i). the newly identified Fic (Filamentation induced by cAMP) protein; and (ii). NDK (Nucleoside Diphosphate Kinase), which had been studied for decades. Fic protein and NDK share several common features: (i). both use nucleoside triphosphate (NTPs) or nucleoside diphosphate (NDPs) or their derivatives as one of their substrates; (ii). they have been found to be involved in diverse cellular pathways, involving different types of substrates that form the second substrate of these proteins; (iii). both are ubiquitously present in all the living organisms - from bacteria to humans to plants. However, there is very little information on these proteins from mycobacterial systems, which include some major human pathogens, Mycobacterium tuberculosis and Mycobacterium leprae, which are the causative agents of Tuberculosis and Leprosy, respectively. In view of these reasons, in the present study, the structural and/or functional features of the Fic and NDK proteins from Mycobacterium tuberculosis, were analysed, as it might be of medical significance for effectively combating the pathogen. The Chapter 1 of the thesis contains the Introduction to the research work and Chapter 2 is on the overall Materials and Methods. The remaining chapters pertain to the data obtained on the structural and/or functional features of the Fic and NDK proteins from Mycobacterium tuberculosis.
Chapter 3. Cloning, Expression and Purification of Mycobacterium tuberculosis Fic
The role of FIC (Filamentation induced by cAMP) domain containing proteins in the regulation of many vital pathways, mostly through the transfer of NMPs from NTPs to specific target proteins (NMPylylation), in microorganisms, higher eukaryotes, and plants is emerging. In order to understand the biological role of FIC domain containing proteins in mycobacteria, the gene for the FIC domain containing protein of the human pathogen, Mycobacterium tuberculosis, MtuFic, was cloned, overexpressed, purified to homogeneity, and biochemically characterised. Neither the His-tagged nor the GST-tagged MtuFic protein, overexpressed in Escherichia coli, nor expression of Mtufic in Mycobacterium smegmatis, yielded the protein in the soluble fraction. However, the maltose binding protein (MBP) tagged MtuFic (MBP-MtuFic) could be obtained partly in the soluble fraction. Denatured-refolded protein was used for the antibody generation in mice and rabbit. The cellular localisation and secretion of MtuFic were characterised using the antibody.
Chapter 4. Biochemical Characterisation of Mycobacterium tuberculosis Fic
Sequence alignment with several FIC motif containing proteins, complemented with homology modeling on the FIC motif containing protein, VbhT of Bartonella schoenbuchensis as the template, showed conservation and interaction of residues constituting the FIC domain. MtuFic, possesses the critical His144 residue, in the characteristic FIC Motif, HPFREGNGRSTR (HPFxxGNGRxxR), spanning 144th to 155th residue. Site-specific mutagenesis of the His144, or Glu148, or Asn150 of the FIC motif, or of Arg87 residue that constitutes the FIC domain, or complete deletion of the FIC motif, abolished the NTP to NMP conversion activity. The activity of MtuFic was consistent with the biochemical activities hitherto reported for a variety of bacterial FIC domain containing proteins. Studies were also carried out on NMPylylation in the presence of eukaryotic proteins and eukaryotic and mycobacterial cell lysates. Although formation of NMPs from NTPs mediated by MBP-MtuFic could be detected, we could not identify any protein as the target substrate either in the human macrophage (THP1) cells or in the
M. tuberculosis cells. VopSΔ30 (kind gift from Dr. Kim Orth), along with human G proteins as targets, were used as the positive controls. Various possibilities for the inability to detect a protein target substrate are discussed.
Chapter 5. Transcriptional Analysis of Mycobacterium tuberculosis fic Gene (Mtufic)
In parallel, in order to understand the transcriptional regulation of Mtufic, primer extension analysis was carried out. The Transcription Start Site (TSS; +1 site) of Mtufic were mapped under different growth/stress conditions, which tubercle bacilli encounter in human host.
Mtufic got expressed mainly through two transcripts, T1 and T2, arising from two different transcription start sites (TSS). Putative promoter regions were cloned in a promoter probe vector, which expresses a GFP protein of very high intensity, in order to qualitatively detect the activity of the promoters. The half-life of the gfp mRNA was determined to be 4 min and therefore justifiably quantitated the Mtufic promoter activity by determining the gfp mRNA levels. The levels of Mtufic mRNA were two-fold higher under nutrient-depleted stationary phase of growth, as compared to the levels at mid-log phase. The activity of P1 and P2, as quantitated real-time using the short half-life gfpm2+ mRNA levels in Mycobacterium smegmatis transformants, showed that the activity of P2 was upregulated two-fold under nutrient-depleted stationary phase of growth, while that of P1 remained unaltered while of P1 and P2 were low under hypoxia. Co-transcription of Mtufic, with the immediate upstream gene, Rv3642c, of unknown function, was observed. Taken together, the data strongly indicated that the expression of Mtufic gets altered under nutrient-depleted and hypoxic conditions, which are the stress conditions experienced by tubercle bacilli in granuloma in tuberculosis patients.
Chapter 6. Functional Characterisation of Mycobacterial FtsZ-NDK Interaction
During the past few decades, our laboratory has been carrying out extensive molecular and functional studies on the cytokinetic protein, FtsZ, of different mycobacterial species, and of a variety of other mycobacterial proteins that are believed to be interacting with the cell division machinery. In this regard, in parallel to the work on MtuFic, we carried out work on the identification and characterisation of the proteins that interact with mycobacterial FtsZ. In this context, we found for the first time that the nucleoside diphosphate kinase (NDK), which can generate NTPs from ATP/GTP and NDPs, interacts with FtsZ and that the interaction was conserved across several mycobacterial species. Therefore, the FtsZ-NDK interaction was extensively characterised in vitro, using the recombinant, purified FtsZ and NDK proteins from different mycobacterial species. This novel finding on the interaction of NDK with FtsZ adds another role to NDK, namely in bacterial cell division.
|
Page generated in 0.0634 seconds